Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml) recalled
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for specific batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml).
Published: 12 March 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for specific batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml).
Curaleaf Laboratories has informed MHRA of a confirmed stability study failure where the THC content is below the acceptable level in Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml).
Pharmacists are advised to stop supplying the affected batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
Further information, advice and details of the affected batches can be found on the MHRA website.